我院2011-2014年呼吸系统药物使用分析

Analysis of the Utilization of Respiratory System Drugs in Our Hospital during 2011-2014

目的:为呼吸系统药物临床合理使用提供参考。方法:对我院2011-2014年使用的呼吸系统药物的种类、销售金额、用药频度(DDDs)等利用Excel进行统计,采用药物利用研究的方法,对DDDs排名前20位的药物进行分析。结果:呼吸系统药物种类、销售金额构成比及DDDs构成比4年来基本不变。中药制剂的品种数销售金额和DDDs构成比均排名第1;而镇咳药构成比最小。2012-2014年平喘药的DDDs构成比由17.06%上升至24.68%,在化学药类呼吸系统药物中占据最重要位置。DDDs排序一直在前10的药物有:氨溴索注射液、布地奈德福莫特罗粉吸入剂、左西替利嗪片/分散片/口服液、金水宝胶囊、吸入用布地奈德混悬剂5个品种。其中,氨溴索注射液DDDs一直排名第1,且逐年上升。结论:我院呼吸系统药物使用基本稳定,中药制剂一直占据重要地位,而镇咳药仅1种,平喘药则占据越来越重要的位置。但氨溴索注射液存在过度使用现象,应引起重视。

OBJECTIVE：To provide reference for rational use of respiratory system drugs.METHODS：The utilization of respiratory system drugs in our hospital during 2011-2014 was analyzed statistically in respects of drug types,consumption sum,DDDs,etc.Top 20 drugs in the list of DDDs was analyzed by using drug utilization study.RESULTS：During 4 years,categories,consumption sum ratios and DDDs ratios of respiratory system drugs showed a stable tendency.The types,consumption sum and DDDs ratios of TCM preparations had dominated the first places for 4 years,while antitussive was always the last one.The DDDs ratios of antiasthma increased from 17.06% to 24.68% during 2011-2014.Antiasthma had dominated the important place in respiratory system drugs.Top 10 drugs in the list of DDDs were Ambroxol injection,Budesonide and formoterol fumarate powder for inhalation,Levocetirizine dihydrochloride tablets/dispersible tablets/oral solution,Jinshuibao capsules,Budesonide suspension for inhalation.Among them,DDDs of Ambroxol injection was increasing year by year and ranked first every year.CONCLUSIONS：It shows a stable tendency in the use of respiratory system drugs.TCM preparations have occupied the most important position among respiratory system drugs,while antitussive show a fading trend.Antiasthma take up a more and more important position.However,we should pay more attention to the overuse of Ambroxol injection.